
TriSalus Life Sciences Hits New 52-Week High at $5.95
2025-11-25 16:26:22TriSalus Life Sciences, Inc. has achieved a new 52-week high of USD 5.95, marking a significant milestone for the microcap company in the Pharmaceuticals & Biotechnology sector. Despite a 1-year performance decline, it maintains a market capitalization of approximately USD 250 million and a notable return on equity of 184.33%.
Read full news articleNo announcement available
Corporate Actions
No corporate action available






